Welcome : Guest

Merck & Co., Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Merck & Co., Inc., which is principally involved in Healthcare Business. Illustrated with 235 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00053
Price: $3500
Company Type: Public
Pages: 247
Date: January 2017
Market Data Tables: 235

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Merck & Co., Inc.’s Sales by Product Category Worldwide (2014-2015) in Percentage for Primary Care and Women’s Health (Cardiovascular, Diabetes, General Medicine and Women’s Health), Hospital and Specialty (Hepatitis, HIV, Hospital Acute Care, Immunology), Oncology, Diversified Brands, Vaccines, Other Pharmaceutical, and Others......11
Table 2: Merck & Co., Inc.’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Pharmaceutical Products, Animal Health Products, Consumer Care Products, and Others......12
Table 3: Merck & Co., Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Europe, Middle East and Africa, Asia-Pacific, Japan, Latin America, and Others......13
Pharmaceuticals......14
Table 4: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......14
Table 5: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......15
Table 6: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......16
Table 7: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......17
Table 8: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......18
Table 9: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......19
Table 10: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......20
Table 11: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......21
Table 12: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......22
Table 13: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......23
Table 14: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......24
Table 15: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......25
Table 16: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......26
Table 17: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......27
Table 18: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......28
Table 19: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......29
Table 20: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......30
Table 21: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......31
Table 22: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......32
Table 23: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......33
Table 24: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......34
Table 25: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......35
Table 26: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......36
Table 27: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......37
Table 28: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......38
Table 29: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......39
Diabetes......40
Table 30: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......40
Table 31: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......41
Table 32: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......42
Table 33: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......43
Table 34: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......44
Table 35: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......45
Table 36: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......46
Table 37: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......47
Table 38: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......48
Table 39: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......49
Diabetes Drugs......50
Table 40: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......50
Table 41: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......51
Table 42: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......52
Table 43: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......53
Table 44: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......54
Table 45: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......55
Table 46: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......56
Table 47: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......57
Table 48: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......58
Table 49: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......59
Table 50: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......60
Non-Insulin Anti-Diabetic Drugs......61
Table 51: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......61
Diabetic Macular Edema (DME)......62
Table 52: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......62
Table 53: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......63
Insulin......64
Table 54: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......64
Table 55: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......65
Table 56: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......66
Table 57: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......67
Table 58: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......68
DPP-4 Inhibitors......69
Table 59: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......69
Table 60: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......70
Table 61: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......71
Table 62: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......72
Table 63: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......73
Table 64: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......74
DPP-4 type Diabetes Drugs......75
Table 65: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......75
Women's Health Drugs......76
Table 66: Women's Health Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Contraceptives, Hormone Therapy, Fertility, and Others......76
Central Nervous System (CNS) Drugs......77
Table 67: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......77
Table 68: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......78
Hepatitis B......79
Table 69: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......79
Table 70: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......80
Table 71: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......81
Hepatitis C......82
Table 72: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others (Includes Ribavirin)......82
Table 73: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......83
Table 74: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......84
Table 75: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......85
Table 76: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......86
Table 77: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......87
Table 78: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......88
Table 79: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......89
HIV Drugs......90
Table 80: HIV Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)/ Nucleoside Reverse Transcriptase Inhibitor (NRTI) Fixed Dose Combination (FDC), Nucleoside Reverse Transcriptase Inhibitor (NRTI)/Retroviral Integrase/CYP3A, Nucleoside Reverse Transcriptase Inhibitor (NRTIs), Protease Inhibitors, Retroviral Integrase (IN), and Others (Includes NNRTIs)......90
Table 81: HIV Regimens for New Start Patients by Segment in European Union (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......91
Table 82: HIV Regimens for Experienced Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Stribild, Truvada and Others......92
Table 83: HIV Regimens for New Start Patients by Segment in the US (2015) - Percentage Market Share Breakdown by Value Sales for Atripla, Compler, Stribild, Truvada and Others......93
Immunology......94
Table 84: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......94
Remicade......95
Table 85: Remicade Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, United States and International......95
Cubicin......96
Table 86: Cubicin Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......96
Cancer......97
Table 87: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......97
Table 88: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......98
Table 89: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......99
Table 90: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......100
Table 91: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......101
Table 92: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......102
Table 93: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......103
Table 94: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......104
Table 95: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......105
Table 96: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......106
Table 97: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......107
Table 98: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......108
Table 99: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......109
Table 100: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......110
Anti-Cancer Drugs......111
Table 101: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......111
Table 102: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......112
Bladder Cancer......113
Table 103: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......113
Breast Cancer......114
Table 104: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......114
Cervical Cancer......115
Table 105: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......115
Table 106: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......116
Colorectal Cancer......117
Table 107: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......117
Hematological Cancer......118
Table 108: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......118
Invasive Breast Cancer......119
Table 109: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......119
Table 110: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......120
Primary Liver Cancer......121
Table 111: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......121
Skin Cancer......122
Table 112: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......122
Cancer in Stage 3/4......123
Table 113: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......123
Solid Cancer Tumor Patients......124
Table 114: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......124
Cancer-Associated Mucositis......125
Table 115: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......125
Cancer Drugs......126
Table 116: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......126
Chronic Lymphocytic Leukemia (CLL)......127
Table 117: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......127
Table 118: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......128
Table 119: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......129
Chronic Myelogenous Leukemia (CML)......130
Table 120: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......130
Cutaneous Melanoma......131
Table 121: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......131
Ocular Melanoma......132
Table 122: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......132
Female Mortality......133
Table 123: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......133
Male Mortality......134
Table 124: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......134
Nausea and Vomiting Associated With Cancer Chemotherapy......135
Table 125: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......135
Multiple Myeloma......136
Table 126: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......136
Table 127: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......137
Non Small Cell Lung Cancer Patients......138
Table 128: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......138
Respiratory Drugs......139
Table 129: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......139
Table 130: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......140
Vaccines......141
Table 131: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......141
Companion Animals......142
Table 132: Companion Animal Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Canada/Latin America, European Union/Africa/Middle East, United States......142
Table 133: Companion Animal Market by Species Worldwide (2015) - Percentage Market Share Breakdown by Value for Cat, Dog, Horse/Others......143
Table 134: Companion Animals Market by Category in Brazil (2015) - Percentage Share Breakdown by Value for Pet Food and Others......144
Table 135: Companion Animals Market by Category in the US (2015) - Percentage Share Breakdown by Value for Pet Food, Pet Healthcare and Other Pet Products......145
Animal Health Market......146
Table 136: Animal Health Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Eastern Europe, Latin America, North America, Western Europe and Rest of World......146
Table 137: Animal Healthcare Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Brazil, China, France, Germany, USA, and Others......147
Table 138: Animal Health Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Biologicals, Feed Additives and Pharmaceuticals......148
Table 139: Animal Health Market by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Companion Animals, and Production Animals......149
Table 140: Animal Health Market by Species Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cattle, Poultry, Sheep, Swine and Companion Animals......150
Table 141: Animal Healthcare Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Infectives, Biologicals, Feed Additives, Parasiticides, and Others......151
Table 142: Animal Health Market by Therapeutic Class Worldwide (2015) - Percentage Share Breakdown by Value for Antibiotics and Therapeutic, Antiparasitic, Foot and Mouth Disease Vaccine, Supplements and Others......152
Table 143: Animal Health Market by Category in Brazil (2015) - Percentage Market Share Breakdown by Value Sales for Companion Animals, and Production Animals......153
Table 144: Animal Health Product Demand by Category in the US (2015) - Percentage Share Breakdown by Value for Companion Animals, Livestock and poultry, and Others......154
Pharmaceutical Benefits Scheme (PBS) Prescription......155
Table 145: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Category in Australia (2015) - Percentage Share Breakdown by Value Sales for Concession Non Safety Net, Concession Safety Net, Doctor's Bag, General Non Safety, and General Safety Net......155
Table 146: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Category in Australia (2015) - Percentage Share Breakdown by Volume Sales for Concession Non Safety Net, Concession Safety Net, Doctor's Bag, General Non Safety, and General Safety Net......156
Table 147: Pharmaceutical Benefits Scheme (PBS) Prescription Market by Company in Australia (2014) - Percentage Market Share Breakdown by Volume Sales for Alphapharm, AstraZeneca Plc, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Merck & Co., Inc., Novartis, Pfizer, Inc., Sanofi S.A., Wyeth, and Others......157
Pharmaceuticals......158
Table 148: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......158
Table 149: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Others......159
Table 150: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......160
Table 151: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......161
Table 152: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......162
Table 153: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......163
Private Pharmaceutical......164
Table 154: Market Shares of Leading Private Pharmaceutical Companies in South Africa (2015) - Percentage Breakdown by Value for Adcock Ingram, Aspen Pharmacare Holdings Ltd., Cipla Ltd., Merck & Co., Inc., Novartis AG, Sanofi S.A., and Others......164
Simvastatin......165
Table 155: Market Shares of Leading Simvastatin Manufacturers in China (2015) - Percentage Share Breakdown by Value for Guangdong Nanxin Pharmaceutical Co., Ltd., Merck & Co., Inc. and Others......165
Diabetes Drugs......166
Table 156: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......166
Table 157: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......167
Table 158: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......168
Insulin......169
Table 159: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......169
Table 160: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......170
Table 161: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......171
Table 162: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......172
Table 163: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......173
Table 164: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......174
Table 165: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......175
Table 166: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......176
Table 167: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......177
Table 168: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......178
Second-Generation Insulin......179
Table 169: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......179
Third-Generation Insulin......180
Table 170: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......180
Human Insulin......181
Table 171: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......181
DPP-4 Inhibitors......182
Table 172: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......182
Table 173: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......183
Table 174: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......184
Sitagliptin/Metformin......185
Table 175: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......185
Table 176: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......186
Table 177: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......187
Table 178: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......188
Metformin......189
Table 179: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......189
Women's Health Therapeutics......190
Table 180: Market Shares of Leading Women's Health Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Merck Ltd., Novo Nordisk A/S, Pfizer, Inc., and Others......190
Hepatitis B Drugs......191
Table 181: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......191
Table 182: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......192
Hepatitis A Vaccines......193
Table 183: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......193
Hepatitis B (Recombinant) Vaccines......194
Table 184: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......194
Hepatitis A and Typhoid Polysaccharide Vaccines......195
Table 185: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......195
Cancer Drugs......196
Table 186: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......196
Table 187: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......197
Table 188: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......198
Breast Cancer Drugs......199
Table 189: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......199
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......200
Table 190: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......200
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......201
Table 191: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......201
Table 192: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......202
Respiratory Therapeutics......203
Table 193: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......203
Vaccines......204
Table 194: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......204
Diphtheria and Tetanus Vaccines......205
Table 195: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......205
Human Papillomavirus Vaccines......206
Table 196: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......206
Human Rotavirus Vaccines......207
Table 197: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......207
Influenza Vaccines......208
Table 198: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......208
Measles, Mumps and Rubella Vaccines......209
Table 199: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......209
Tetanus Toxoid, reduced Diphthera Vaccines......210
Table 200: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......210
Typhoid Vaccines......211
Table 201: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......211
Varilrix Vaccines......212
Table 202: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......212
Central Nervous System (CNS) Medicines......213
Table 203: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......213
Table 204: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......214
Sun Care Products......215
Table 205: Market Shares of Leading Sun Care Product Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amorepacific Corporation, Avon Products, Inc., Beiersdorf AG, Colgate-Palmolive Company, Energizer Holdings, Inc., Estée Lauder Companies, Inc., L'Oréal Group, Merck & Co., Inc., Shiseido Co., Ltd. and Others......215
Table 206: Market Shares of Leading Sun Care Product Manufacturers by Value Sales in Latin America (2014) - Percentage Breakdown for Avon Products, Inc., Beiersdorf AG, Botica, Inc., Chanel S.A., Colgate-Palmolive Company, Energizer Holdings, Inc., Hypermarcas S.A., L'Oréal Group, Merck & Co., Inc. and Others......216
Table 207: Market Shares of Leading Sun Care Product Manufacturers by Value Sales in North America (2014) - Percentage Breakdown for Australian Gold, Clarins Group, Colgate-Palmolive Company, Energizer Holdings, Inc., Estée Lauder Companies, Inc., L'Oréal Group, Mary Kay, Inc., Merck & Co., Inc., Sun And Skin Care Research, LLC. and Others......217
Cough/Cold Medicines......218
Table 208: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others......218
Table 209: Market Shares of Leading Cough and Cold Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Johnson & Johnson Private Limited, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Private-Label and Others......219
Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine......220
Table 210: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......220
Therapeutic Dermatology (excluding Aesthetics) Medicines......221
Table 211: Market Shares of Leading Therapeutic Dermatology (excluding Aesthetics) Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Inc. (ABBV), Galderma S.A., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Pfizer, Inc. (PFE), Amgen, Inc. (AMGN), Valeant Pharmaceuticals Intl, Inc., Dermik Laboratories, and Others......221
Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs......222
Table 212: Market Shares of Leading Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Co (BMY), GlaxoSmithKline Plc (GSK), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Vertex Pharmaceuticals, Inc. (VRTX), and Others......222
Over-The-Counter (OTC)......223
Table 213: Market Shares of Leading Over-the-Counter (OTC) Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Procter & Gamble Co., Reckitt Benckiser Plc, Sanofi S.A., Private-Label and Others......223
Pediatric Health Product......224
Table 214: Market Shares of Leading Pediatric Health Product Manufacturers in the US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Merck & Co., Inc., Novartis AG, Pfizer Inc, Prestige Brands Holdings Inc, Reckitt Benckiser Plc, Private-Label and Others......224
Consumer Health Products......225
Table 215: Market Shares of Leading Consumer Health Product Manufacturers in US (2015) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson Inc, Living Essentials, Merck & Co., Inc., NBTY, Inc., Novartis AG, Pfizer Inc, Procter & Gamble Co., Private-Label and Others......225
Parasiticides......226
Table 216: Market Shares of Leading Parasiticides Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Merial, Novartis AG, Zoetis, Inc. and Others......226
Biologics/Vaccines......227
Table 217: Market Shares of Leading Biologics/Vaccines Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......227
Anti-Infectives......228
Table 218: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Others......228
Medical Feed Additives......229
Table 219: Market Shares of Leading Medical Feed Additives Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Zoetis, Inc. and Others......229
Sun Care Products......230
Table 220: Market Shares of Leading Sun Care Products Manufacturers by Retail Channel Sales in North America (2015) - Percentage Share Breakdown by Value for Colgate-Palmolive Co., Energizer Holdings, Inc., Estée Lauder Companies, Inc., L'Oréal S.A., Merck & Co., Inc., and Others......230
Cold, Allergy and Sinus Remedy (Tablet, Packet)......231
Table 221: Market Shares of Leading Cold, Allergy and Sinus Remedy (Tablet, Packet) Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Chattem Chemicals, Inc., McNeil Consumer Healthcare, Merck & Co., Inc., RB plc, Private Label, and Others......231
DPP-4 Drugs......232
Table 222: Market Shares of Leading DPP-4 Drugs Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Merck & Co., Inc., Novartis AG, and Others......232
Veterinary Services......233
Table 223: Market Shares of Leading Veterinary Services Providers Worldwide (2015) - Percentage Share Breakdown by Value for Bayer AG, Eli Lilly and Company (Elanco), Merck & Co., Sanofi (Merial), Zoetis, Inc. and Others......233
Poultry Pharmaceuticals......234
Table 224: Market Shares of Leading Pharmaceutical Companies for Poultry Worldwide (2015) - Percentage Breakdown by Value for Ceva, Eli Lilly and Company, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......234
Drugs for Companion Animals......235
Table 225: Market Shares of Leading Pharmaceutical Companies for Companion Animal Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Merial, Novartis AG, Zoetis, Inc. and Others......235
Animal Healthcare......236
Table 226: Market Shares of Leading Animal Healthcare Companies by Value Sales Worldwide (2015) - Percentage Breakdown for Bayer AG, C.H. Boehringer Sohn AG & Ko., Eli Lilly and Company, Merck & Co., Inc., Merial, Zoetis, Inc., and Others......236
Table 227: Market Shares of Leading Animal Healthcare Companies by Value Sales in Brazil (2015) - Percentage Breakdown for Merck & Co., Inc., Merial, Ourofino, Vallée, Zoetis, Inc., and Others......237
Livestock......238
Table 228: Market Shares of Leading Pharmaceutical Companies for Livestock Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......238
Cattle Pharmaceuticals......239
Table 229: Market Shares of Leading Pharmaceutical Companies for Cattle Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Eli Lilly and Company, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......239
Pigs Pharmaceuticals......240
Table 230: Market Shares of Leading Pharmaceutical Companies for Pigs Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Zoetis, Inc. and Others......240
Sheep Pharmaceuticals......241
Table 231: Market Shares of Leading Pharmaceutical Companies for Sheep Worldwide (2015) - Percentage Breakdown by Value for Ceva, Merck & Co., Inc., Merial, Novartis AG, Zoetis, Inc. and Others......241
Table 232: Merck & Co., Inc.’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Europe, Middle East and Africa, Japan, Asia-Pacific, Latin America and Others......242
Table 233: Merck & Co., Inc.’s Sales by Product Segment Worldwide (2013) in Percentage for Cardiovascular, Diabetes and Obesity, Respiratory, Women's Health and Endocrine, Hospital and Specialty, Immunology, Infectious Disease, Oncology, Cosopt/Trusopt, Diversified Brands and Vaccines......243
Table 234: Merck & Co., Inc.'s Animal Health Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for United States and Rest of the World......244
Table 235: Merck & Co., Inc.'s Animal Health Sales by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Companion and Livestock......245